Amgen Seeks to Monopolize Nature

The Supreme Court received an excessive patent seeking to preempt a competitor’s pharmaceutical product.

https://www.wsj.com/articles/amgen-seeks-to-monopolize-nature-cholesterol-atomic-structure-patent-court-innovation-pcsk9-6c746d5d Amgen Seeks to Monopolize Nature

Edmuns DeMars

Edmund DeMarche is a USTimesPost U.S. News Reporter based in London. His focus is on U.S. politics and the environment. He has covered climate change extensively, as well as healthcare and crime. Edmund DeMarche joined USTimesPost in 2023 from the Daily Express and previously worked for Chemist and Druggist and the Jewish Chronicle. He is a graduate of Cambridge University. Languages: English. You can get in touch with me by emailing edmund@ustimespost.com.

Related Articles

Back to top button